BE896291A - 3,4-DIAMINO-1,2,5-THIADIAZOLES SUBSTITUTED HAVING HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY - Google Patents

3,4-DIAMINO-1,2,5-THIADIAZOLES SUBSTITUTED HAVING HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY

Info

Publication number
BE896291A
BE896291A BE0/210417A BE210417A BE896291A BE 896291 A BE896291 A BE 896291A BE 0/210417 A BE0/210417 A BE 0/210417A BE 210417 A BE210417 A BE 210417A BE 896291 A BE896291 A BE 896291A
Authority
BE
Belgium
Prior art keywords
histamine
diamino
receptor antagonist
antagonist activity
thiadiazoles
Prior art date
Application number
BE0/210417A
Other languages
French (fr)
Inventor
R R Crenshaw
A A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE896291A publication Critical patent/BE896291A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE0/210417A 1982-03-29 1983-03-28 3,4-DIAMINO-1,2,5-THIADIAZOLES SUBSTITUTED HAVING HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY BE896291A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
BE896291A true BE896291A (en) 1983-09-28

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210417A BE896291A (en) 1982-03-29 1983-03-28 3,4-DIAMINO-1,2,5-THIADIAZOLES SUBSTITUTED HAVING HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY

Country Status (30)

Country Link
JP (2) JPS58180477A (en)
KR (1) KR880002209B1 (en)
AT (1) AT386599B (en)
AU (2) AU557577B2 (en)
BE (1) BE896291A (en)
CH (2) CH655111A5 (en)
CS (2) CS250240B2 (en)
DD (2) DD219768A5 (en)
DE (1) DE3311281A1 (en)
DK (2) DK166677B1 (en)
ES (3) ES8404683A1 (en)
FR (2) FR2542741B1 (en)
GB (2) GB2117769B (en)
GR (1) GR78524B (en)
HU (2) HU188742B (en)
IE (1) IE55596B1 (en)
IL (1) IL68259A0 (en)
IT (1) IT1164633B (en)
LU (1) LU84716A1 (en)
MY (1) MY8700942A (en)
NL (1) NL8301063A (en)
NO (1) NO163055C (en)
NZ (1) NZ203726A (en)
OA (1) OA07356A (en)
PT (1) PT76459B (en)
SE (2) SE461040B (en)
SU (2) SU1419518A3 (en)
YU (1) YU44849B (en)
ZA (1) ZA832154B (en)
ZW (1) ZW7683A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (en) * 1986-06-30 1994-03-30 フアナツク株式会社 Direct pressure type mold clamping mechanism
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
NL189197C (en) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-SUBSTITUTED-1,2,5-THIADIAZOLO-1-OXIDES AND 1,1-DIOXIDES, PREPARATION THEREOF, AND PHARMACEUTICAL PREPARATIONS.
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
DK81192A (en) 1992-06-18
JPH06135925A (en) 1994-05-17
KR880002209B1 (en) 1988-10-18
GR78524B (en) 1984-09-27
SE8301725L (en) 1983-11-25
JPH0568472B2 (en) 1993-09-29
SE461040B (en) 1989-12-18
GB8308518D0 (en) 1983-05-05
NO163055B (en) 1989-12-18
IT1164633B (en) 1987-04-15
DD219768A5 (en) 1985-03-13
DK141383D0 (en) 1983-03-28
CS250240B2 (en) 1987-04-16
DK81192D0 (en) 1992-06-18
DK166677B1 (en) 1993-06-28
FR2542741B1 (en) 1989-12-08
YU74483A (en) 1986-02-28
CH660880A5 (en) 1987-05-29
AU557577B2 (en) 1986-12-24
FR2597867B1 (en) 1989-12-08
NL8301063A (en) 1983-10-17
SU1355123A3 (en) 1987-11-23
AU586037B2 (en) 1989-06-29
AT386599B (en) 1988-09-12
LU84716A1 (en) 1983-12-05
ES520982A0 (en) 1984-05-16
ES8404683A1 (en) 1984-05-16
DE3311281A1 (en) 1983-11-24
ES527686A0 (en) 1985-06-16
SE464302B (en) 1991-04-08
SE8704689D0 (en) 1987-11-25
GB2117769B (en) 1985-08-29
YU44849B (en) 1991-04-30
MY8700942A (en) 1987-12-31
GB2149406B (en) 1986-01-02
DK141383A (en) 1983-09-30
GB2149406A (en) 1985-06-12
PT76459A (en) 1983-04-01
HU196386B (en) 1988-11-28
FR2597867A1 (en) 1987-10-30
NO163055C (en) 1990-03-28
ZA832154B (en) 1983-12-28
CH655111A5 (en) 1986-03-27
KR840004095A (en) 1984-10-06
OA07356A (en) 1984-08-31
NZ203726A (en) 1986-05-09
PT76459B (en) 1986-03-11
NO831100L (en) 1983-09-30
IT8348005A0 (en) 1983-03-28
ES527685A0 (en) 1985-06-16
ATA111083A (en) 1988-02-15
SU1419518A3 (en) 1988-08-23
GB2117769A (en) 1983-10-19
ZW7683A1 (en) 1984-01-04
HU188742B (en) 1986-05-28
GB8432809D0 (en) 1985-02-06
IE830686L (en) 1983-09-29
AU1290783A (en) 1983-10-06
SE8704689L (en) 1987-11-25
ES8505978A1 (en) 1985-06-16
CS250229B2 (en) 1987-04-16
IE55596B1 (en) 1990-11-21
IL68259A0 (en) 1983-06-15
FR2542741A1 (en) 1984-09-21
ES8505977A1 (en) 1985-06-16
SE8301725D0 (en) 1983-03-28
AU6327286A (en) 1987-01-08
JPS58180477A (en) 1983-10-21
DD210909A5 (en) 1984-06-27

Similar Documents

Publication Publication Date Title
DE3577547D1 (en) 2- (2'-NITROBENZOYL) -1,3-CYCLOHEXANDIONEN.
TR22585A (en) SOME 2- (2'-ALKILBENZOIL) -1,3-SIKLOHEKSANDIONS
ATE40361T1 (en) 2,2'-IMINOBISAETHANOL DERIVATIVES.
FI820856L (en) 2-PHENOXIALKYL-1,2,4-TRIAZOL-3-ON ANTIDEPRESSIVER
FR2569144B1 (en) DEVICE FOR ADJUSTING A SUSPENSION
FR2561595B1 (en) ADJUSTING DEVICE FOR SEAT
ES265752Y (en) "SEAT BELT ARRANGEMENT".
DE3475713D1 (en) 3, 3 ", 4" TRI-O-ACYL SPIRAMYCIN I
FR2542741B1 (en) 3,4-DIAMINO-1,2,5-THIADIAZOLES SUBSTITUTED HAVING HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY
FR2566406B1 (en) SUBSTITUTED 3,4-DIAMINO-1,2,5-THIADIAZOLES WITH HISTAMINE H2 RECEPTOR ANTAGONIST ACTIVITY
IT8422192A0 (en) PART PROTECTED FROM WEAR.
FI822999L (en) 3'-SUBSTITUTE 5 '- (2-AMINO-4-PYRIDYL) -1', 2 ', 4'-TRIAZOLER
IT8422744A1 (en) 4 (3H) -PYRIMIDONS 2,5-SUBSTITUTED HAVING ACTIVITIES! ANTAGONIST OF HISTAMINE H2 RECEPTORS
ES266710Y (en) "BUCKET FEEDER".
ES264760Y (en) "BALIZATION MILESTONE".
ES267903Y (en) "COPYING TOOL".
ES265398Y (en) DETACHABLE HINGE.
ES264448Y (en) "IMPROVED ANTI-THEFT".
IT8304829A0 (en) ADVANCE MACHINE FOR THE CONSTRUCTION OF TUNNELS.
ES262782Y (en) "IMPROVED MOUSE PAD".
IT8319120V0 (en) WRITING AT 15 ', AT 30', AT 45 '
IT8317713A0 (en) WRITING AT 15', 30', 45'
IT8223991A0 (en) NEW 2,2-DISOSTITUTED 2,3-DIHYDRO-1,4-BENZODIOXINES WITH HYPOTENSIVE ACTIVITY.
IT8203521A0 (en) BOOK FOR DRAFTING THE AUTOBIOGRAPHY
ES266919Y (en) "PERFECTED HINGE".

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19950331